GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

The FDA has form on this issue, rejecting GSK’s IL-5 inhibitor Nucala (mepolizumab) last year for COPD because it felt that the data on exacerbations wasn’t strong enough. Trelegy – based on ...

In September 2020, the Company launched tetravalent influenza flu vaccine, Fluarix Tetra to help combat influenza.In June, 2021 Company launched the Nucala, first anti-IL5 drug, auto-injector ...

The success of Dupixent has demonstrated the viability of biologics in COPD. (Image Credits: Pixabay) AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be ...

The chronic obstructive pulmonary disease (COPD) market continues its trajectory of rapid growth, bolstered by significant advancements in biologics and sustained investments by major ...

Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...

A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments. Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

· Approval based on RUBY Part 1 trial, which showed a median overall survival (OS) of 44.6 months for Jemperli plus chemotherapy vs. 28.2 months for chemotherapy alone · Jemperli plus ...

The pre-dawn blaze broke out at a popular resort during a school break. Some survivors spoke of terrifying escapes. By Ben Hubbard and Safak Timur Axel Rudakubana, who killed three young girls ...